Your browser doesn't support javascript.
loading
Unlocking the Potential of Ru(II) Dual-action Compounds with the Power of the Heavy-atom Effect.
Toupin, Nicholas P; Steinke, Sean J; Herroon, Mackenzie K; Podgorski, Izabela; Turro, Claudia; Kodanko, Jeremy J.
Afiliación
  • Toupin NP; Department of Chemistry, Wayne State University, Detroit, MI.
  • Steinke SJ; Department of Chemistry and Biochemistry, The Ohio State University, Columbus, OH.
  • Herroon MK; Department of Pharmacology, School of Medicine, Wayne State University, Detroit, MI.
  • Podgorski I; Department of Pharmacology, School of Medicine, Wayne State University, Detroit, MI.
  • Turro C; Department of Chemistry and Biochemistry, The Ohio State University, Columbus, OH.
  • Kodanko JJ; Department of Chemistry, Wayne State University, Detroit, MI.
Photochem Photobiol ; 98(2): 378-388, 2022 03.
Article en En | MEDLINE | ID: mdl-34866185
We report the synthesis, photochemical and biological characterization of two new Ru(II) photoactivated complexes based on [Ru(tpy)(Me2 bpy)(L)]2+ (tpy = 2,2':6',2''-terpyridine, Me2 bpy = 6,6'-dimethyl-2,2'-bipyridine), where L = pyridyl-BODIPY (pyBOD). Two pyBOD ligands were prepared bearing flanking hydrogen or iodine atoms. Ru(II)-bound BODIPY dyes show a red-shift of absorption maxima relative to the free dyes and undergo photodissociation of BODIPY ligands with green light irradiation. Addition of iodine into the BODIPY ligand facilitates intersystem crossing, which leads to efficient singlet oxygen production in the free dye, but also enhances quantum yield of release of the BODIPY ligand from Ru(II). This represents the first report of a strategy to enhance photodissociation quantum yields through the heavy-atom effect in Ru(II) complexes. Furthermore, Ru(II)-bound BODIPY dyes display fluorescence turn-on once released, with a lead analog showing nanomolar EC50 values against triple negative breast cancer cells, >100-fold phototherapeutic indexes under green light irradiation, and higher selectivity toward cancer cells as compared to normal cells than the corresponding free BODIPY photosensitizer. Conventional Ru(II) photoactivated complexes require nonbiorthogonal blue light for activation and rarely show submicromolar potency to achieve cell death. Our study represents an avenue for the improved photochemistry and potency of future Ru(II) complexes.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Rutenio / Yodo Idioma: En Revista: Photochem Photobiol Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Rutenio / Yodo Idioma: En Revista: Photochem Photobiol Año: 2022 Tipo del documento: Article